CSPC Pharmaceutical Group (HK:1093) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CSPC Pharmaceutical Group Limited has renewed its Master Purchase Agreement with CHL, extending their previous arrangement for purchasing products beyond the original estimate and expiration, now set to last from 1 July 2024 to 30 June 2027. This new agreement, which involves transactions with a connected person, adheres to the Listing Rules and is subject to regular reporting and review obligations. The terms of the renewed agreement promise competitive market pricing and commercial fairness for CSPC.
For further insights into HK:1093 stock, check out TipRanks’ Stock Analysis page.